Multipayer Primary Care Transformation: Impact for Medicaid Managed Care BeneficiariesNovember 21st 2019
The Michigan Primary Care Transformation project generated cost savings among adults in Medicaid managed care, particularly high-risk adults, while largely maintaining quality of care.
Importance of Reasons for Stocking Adult VaccinesNovember 20th 2019
Economic factors associated with the purchase and maintenance of vaccine inventory and inadequate reimbursement for vaccination services were the most important to pharmacy and doctors’ office decision makers when considering whether to stock adult vaccines.
Prescribing Trend of Pioglitazone After Safety Warning Release in KoreaNovember 19th 2019
The pioglitazone safety warning issued in South Korea, which recommended prescribing with careful attention among those with high risk of bladder cancer, led to a moderate decrease in pioglitazone users.
Cost Analysis of COPD Exacerbations and Cardiovascular Events in SUMMITNovember 18th 2019
This cost analysis using data from the Study to Understand Mortality and Morbidity in COPD (SUMMIT) trial found that fluticasone furoate/vilanterol reduced the rates and costs of combined chronic obstructive pulmonary disease (COPD) exacerbations and revascularization/cardiovascular events versus placebo.
Comprehensive Health Management Pharmacist-Delivered Model: Impact on Healthcare Utilization and CostsNovember 14th 2019
Pharmacist-provided comprehensive medication management led to a significant difference in emergency department visits and a cost savings of $2.10 to $2.60 for every $1.00 spent relative to a comparator group.
Multimodality Cancer Care and Implications for Episode-Based Payments in CancerNovember 12th 2019
Most patients receiving multimodality cancer care receive care from different practices. Therefore, episode-based payments in oncology must hold multiple providers accountable for costs and quality.
CKD Quality Improvement Intervention With PCMH Integration: Health Plan ResultsNovember 8th 2019
A scalable chronic kidney disease (CKD) quality improvement intervention demonstrated feasibility, decreased hospitalization, and reduced costs. These preliminary results support innovation in CKD by commercial health plans.